News

Seegene Launches Innovative mpox Detection Assays for Research

Seegene Launches Innovative mpox Detection Assays for Research

Seegene Introduces Innovative Solutions for mpox Detection

In a significant step forward for public health, Seegene Inc. has unveiled its latest product, the Novaplex™ MPXV/OPXV plus Assay. This state-of-the-art research-use-only (RUO) assay is specifically designed to identify and detect the mpox virus, particularly the more transmissible and deadly Clade I, which poses greater risks than Clade II.

Enhanced Accuracy with the New Assay

Distinctive Features of the Novaplex™ Assay

The Novaplex™ MPXV/OPXV plus Assay can accurately detect non-variola Orthopoxvirus (OPXV) along with the mpox virus (MPVX). Importantly, it confirms MPXV Clade I infections with high precision, providing essential support to healthcare professionals in their research, especially amidst the ongoing challenges posed by the spread of mpox.

Compliance with International Health Standards

Aligned with the World Health Organization's (WHO) target product profiles, Seegene's latest assay ensures accurate detection of viral strains. By following these guidelines, the assay helps healthcare professionals identify new mpox cases with precision, thereby contributing effectively to global health initiatives.

Global Health Response Efforts

Seegene has taken a proactive stance in tackling the recent global public health crisis related to mpox. The WHO has categorized the mpox outbreak as a Public Health Emergency of International Concern (PHEIC), prompting Seegene to create two new assays aimed at meeting urgent global health needs.

Alongside the Novaplex™ MPXV/OPXV Assay (RUO), the company has also developed the Novaplex™ HSV-1&2/VZV/MPXV Assay (RUO), which detects four viruses simultaneously, including mpox and various strains of the herpes virus. Both assays meet WHO criteria, ensuring that researchers have the necessary tools to effectively address the spread of these viruses.

Dedication to Addressing the Spread of mpox

Daniel Shin, Seegene’s Executive Vice-President and Chief Global Sales and Marketing Officer, emphasized the company’s commitment to combating the mpox virus. "As we observe the ongoing spread of mpox, we are ramping up our efforts to develop RUO assays that meet the urgent research needs of affected countries,” he stated.

The Wider Implications of mpox

To put the current situation into perspective, the Africa Centres for Disease Control and Prevention has reported concerning figures from January to September 2024, with over 24,851 suspected cases and 5,549 confirmed cases. This highlights the critical need for effective detection methods.

Moreover, mpox is spreading beyond its usual regions, with cases now reported in countries such as Sweden, Pakistan, and Thailand. This global expansion emphasizes the urgent necessity for advanced detection solutions.

About Seegene

With over 23 years of experience in research, development, and manufacturing focused on multiplex PCR technologies, Seegene has gained international recognition. Their capabilities were particularly highlighted during the pandemic, allowing them to provide over 340 million COVID-19 tests to more than 100 countries. Seegene’s technology, which enables simultaneous testing for multiple pathogens, is crucial for addressing global health challenges.

Frequently Asked Questions

What is the Novaplex™ MPXV/OPXV plus Assay?

The Novaplex™ MPXV/OPXV plus Assay is a new PCR assay designed to detect mpox Clade I and other Orthopoxviruses to support research efforts globally.

Why is mpox Clade I concerning?

MPXV Clade I poses higher transmission and mortality risks compared to other variants, making accurate detection critically important.

How does Seegene's assay help healthcare professionals?

By adhering to WHO standards and accurately diagnosing infections, the assay provides healthcare professionals necessary insights for managing outbreaks.

What other products have been developed by Seegene?

In addition to the new mpox assays, Seegene also offers assays that test for herpes simplex viruses, significantly broadening the scope of their research utility.

What is Seegene's experience in diagnostics?

With decades of experience, Seegene is recognized for its advanced PCR technology and for delivering millions of tests to tackle global health crises effectively.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Teamsters Secure Strong Contract for CA Waste Workers

Updated Category News Views 99

Teamsters Flex Muscles in So-Cal Sanitation Sector So here's one for the books: 700 Waste Management workers represented by Teamsters Local 396 just locked down a fresh collective bargaining agreement in Los Angeles and Orange counties. And let me tell you, this isn’t just another contract—it's a testament to what solidarity can wring out of a massive corporation. The...

Continue Reading
WuXi AppTec Boosts Guidance Amid Strong CRDMO Growth

Updated Category News Views 208

Unpacking WuXi AppTec's Latest Performance Boost WuXi AppTec, the pharmaceutical giant, isn't just coasting on its past successes. The way they're riding the contract research, development, and manufacturing (CRDMO) train straight through Q1 to Q3 of 2026 shows they're not just here for show. They've hiked up the stakes with strong metrics across the board, warranting a...

Continue Reading
Marc Jacobs Expansion: Bold Moves, Bigger Markets

Updated Category News Views 64

Marc Jacobs' Bold Move into Greater China There's a new gust blowing through the retail fashion industry, and it's coming from the partnership between WHP Global, G-III Apparel Group, and I.T Group. These seasoned players are betting big on Marc Jacobs to expand its footprint in the Greater China region. I can practically see the dollar signs in their eyes as they dive...

Continue Reading
DropGenie Nets $5M to Boost Functional Biology Reach

Updated Category News Views 133

DropGenie Scores Big with Fresh Financing Boost Out of the Montreal wilderness, DropGenie is charging forward with a fresh $5 million injection in Seed+ financing. This isn't just loose change; it's a ticket to accelerating their mission of advancing functional biology platforms and beefing up data partnerships. You know, the kind of partnerships that even the suits in...

Continue Reading
United Vein Expands Vero Beach Network for Specialized Care

Updated Category News Views 175

Simplifying Vein Healthcare in Vero Beach Out of all the surprises life throws, leg cramps and bulging veins seem like small potatoes—until they're not. That's why folks in Vero Beach got a new lifeline today with the United Vein & Vascular Centers opening another clinic. At the crossroads of the 37th Street medical district, this place puts specialized vein care right...

Continue Reading
Trip.com Drives Sustainability with New Travel Impact Tool

Updated Category News Views 55

Sustainability Takes Center Stage in Travel Plans So here's the deal: Traveling isn't just about snapping pictures of breathtaking views or rounding up souvenirs anymore. These days, people are increasingly keen on ensuring their trips don't leave a hefty carbon footprint. With the release of Trip.com's 2026 Sustainable Travel Consumer Report, it's clear that the winds...

Continue Reading
Duke Energy's Battle Against Energy Vampires Heats Up

Updated Category News Views 248

Unplugging Hidden Electricity Drains Ever wonder why your electric bill has been sneakily creeping up? You might think it's just the AC running full blast or lights left on, but surprise, surprise—there’s a whole army of “energy vampires” quietly sucking the juice out of your home. Duke Energy Florida is drawing attention to this sneaky leak, especially around...

Continue Reading
EQS Group's Climate Goals Get SBTi Validation

Updated Category News Views 90

EQS Group's Bold Climate Commitments The news hits like a gust of clean air — EQS Group's climate targets are now stamped with the seal of approval from the Science Based Targets initiative (SBTi). This isn't just your typical corporate green pledge: we're talking serious, validated commitments pushing for net-zero emissions by 2050. Decoding EQS Group's Impactful...

Continue Reading
SWI Compute's Bold Move: Transforming Power Into AI

Updated Category News Views 180

The Power Play: From Grid to AI If you think turning megawatts into money-making machines is a stretch, think again. SWI Compute is daringly striding into this territory with the launch of its NVIDIA AI factories in Europe, backed by a hefty 3.6 gigawatts of secured power capacity. It's not just talk; they've got the juice, both in electricity and ambition, to boot....

Continue Reading
Amgen's Board Gains Restaurateur Gibbs Amid Strategic Shift

Updated Category News Views 68

A Heavyweight Joiner Shakes Up Amgen's Ranks You can almost feel the ground shake when Amgen, a tech giant in biotech, ropes in a high-profile namesake from outside its usual league. David W. Gibbs, the former CEO of Yum! Brands, is now staking his claim at Amgen as a member of its Board of Directors. Effective immediately, Gibbs isn’t just a filler; he's diving...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring the Growth of Cheniere Energy Investments Over Time

Updated Category News Views 164

Understanding Cheniere Energy's Investment Growth Cheniere Energy (NYSE: LNG) has emerged as a strong performer in the market over the past decade and a half, delivering impressive returns that outstrip many indices. Investors have significantly benefited from the smart and strategic positioning of the company in the energy sector. Annual Returns of Cheniere Energy Over...

Continue Reading
Manhattan Bridge Capital Announces New Quarterly Dividend Plans

Updated Category News Views 96

Manhattan Bridge Capital Announces New Quarterly Dividend Plans Located in Great Neck, New York, Manhattan Bridge Capital, Inc. (NASDAQ: LOAN) continues to demonstrate its commitment to returning value to its shareholders. The company recently announced a quarterly dividend of $0.115 per share, reaffirming its position in the competitive financial landscape. Understanding...

Continue Reading
Mural Oncology Shareholders Approve Acquisition by XRA 5 Corp

Updated Category News Views 205

Mural Oncology Shareholders Approve Acquisition by XRA 5 Corp Mural Oncology plc (NASDAQ: MURA), a leader in developing immunotherapies, has secured significant approval from its shareholders regarding a pivotal acquisition by XRA 5 Corp., a subsidiary of XOMA Royalty Corporation (NASDAQ: XOMA). During recent shareholder meetings, the overwhelming majority endorsed the...

Continue Reading
ARTIS Zoo's New Certification: A Win for Urban Wildlife

Updated Category News Views 208

A New Dawn for Nocturnal Wildlife at ARTIS Zoo Next to a vibrant scene, Amsterdam now boasts a remarkable dark zone. Royal Zoo ARTIS has proudly earned the title of Urban Night Sky Place from DarkSky International. This landmark achievement marks ARTIS as the first zoo within a European capital to receive such an honor, and it stands out as the first zoo worldwide to...

Continue Reading
iBio Secures Board Investments to Boost Obesity Treatments

Updated Category News Views 156

iBio Secures Major Investments from Leadership In a recent announcement, iBio, Inc. has revealed that it has successfully closed a private placement offering with prominent members of its Board of Directors and corporate officers, amassing over $650,000 in funding. This significant financial backing highlights the confidence that the board members have in iBio's vision...

Continue Reading